Optogenetically-inspired neuromodulation: Translating basic discoveries into therapeutic strategies.

Area of Science:

• Neuroscience
• Neuromodulation
• Psychiatric Disorders

Background:

• Optogenetic tools offer precise control over genetically defined neural circuits.
• Preclinical optogenetic studies have significantly advanced understanding of psychiatric disorders' neural circuit basis.
• Deep brain stimulation (DBS) is the only current clinical neuromodulation treatment for psychiatric disorders, but its mechanisms remain unclear.

Purpose of the Study:

• To explore how optogenetic tools can elucidate the mechanisms of deep brain stimulation (DBS) in psychiatric and neurological disorders.
• To review how optogenetics has been used to understand DBS effects in movement and compulsive disorders.
• To highlight the translational potential of optogenetics in guiding novel DBS protocols and optimizing stimulation paradigms.

Main Methods:

• Review of preclinical studies utilizing optogenetic tools to investigate neural circuits.
• Analysis of research employing optogenetics to induce plasticity and alter basal ganglia circuit function.
• Evaluation of behavioral outcomes in response to optogenetically-induced circuit modulation.

Main Results:

• Optogenetics has been instrumental in reverse-engineering the mechanisms underlying DBS for movement and compulsive disorders.
• Studies demonstrate optogenetics' ability to induce plasticity and modify neural circuit function, impacting behavior.
• Optogenetic research provides a mechanistic rationale for targeting specific neural circuits in DBS.

Conclusions:

• Optogenetics, while not directly clinical, is crucial for understanding DBS mechanisms and inspiring new therapeutic strategies.
• The insights gained from optogenetics can lead to the development of more targeted and effective DBS protocols.
• Optogenetics aids in establishing optimal stimulation parameters to address pathological neural plasticity in psychiatric disorders.